Voyager Therapeutics Inc
(NAS:VYGR)
$
5.78
0.11 (1.94%)
Market Cap: 315.74 Mil
Enterprise Value: 15.72 Mil
PE Ratio: 8.89
PB Ratio: 0.95
GF Score: 75/100 Voyager Therapeutics Inc at Morgan Stanley Healthcare Conference Transcript
Sep 10, 2019 / 06:05PM GMT
Release Date Price:
$17.07
(+3.20%)
Jeff Hung
Morgan Stanley, Research Division - Equity Analyst
Welcome everyone to the Morgan Stanley Global Health Care Conference. I am Jeff Hung, one of the biotech analysts.
Before we start, please note that all important disclosures including personal holdings disclosure and Morgan Stanley disclosures appear on the Morgan Stanley public website at www.morganstanley.com/researchdisclosures or at the registration desk.
For this session, we have Andre Turenne, CEO of Voyager Therapeutics. Welcome.
G. Andre Turenne
Voyager Therapeutics, Inc. - CEO, President & Director
Thanks, Jeff.
Jeff Hung
Morgan Stanley, Research Division - Equity Analyst
So maybe for those in the room who may not be as familiar with Voyager, can you provide a brief introduction?
G. Andre Turenne
Voyager Therapeutics, Inc. - CEO, President & Director
Yes. And thank you for the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot